About 312 results
Open links in new tab
  1. Pipeline – Enveric Biosciences

    While Enveric’s primary focus remains on advancing EB-003 toward clinical trials, advancing the EVM401 series reinforces the Company’s commitment to expanding its pipeline and driving …

  2. Enveric Biosciences Receives Notice of Allowance for EVM301 …

    1 day ago · The compositions claims and methods of use claims covered by this patent will further broaden Enveric’s pipeline by covering additional potential neuroplastogenic non …

  3. Enveric Biosciences Receives Fourth Notice of Allowance for …

    Nov 26, 2025 · By leveraging a differentiated drug discovery platform and a growing library of protected chemical structures, Enveric is advancing a pipeline of novel compounds designed …

  4. Enveric Biosciences Selects EB-003 as Lead Drug Candidate from …

    Dec 28, 2023 · “Importantly, moving EB-003 into our development pipeline marks a transformative step for Enveric as we complete our period as a discovery phase company and fully transition …

  5. SEC Filings – Enveric Biosciences

    Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or use of a …

  6. Enveric Biosciences Secures Second U.S. Patent Allowance for Next ...

    Jul 23, 2025 · “The expansion of the EVM401 Series reflects Enveric’s commitment to developing a deep pipeline of next-generation, non-hallucinogenic neuroplastogens that align with the …

  7. Press Releases – Enveric Biosciences

    Oct 16, 2025 · Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

  8. Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent …

    Oct 15, 2025 · By leveraging a differentiated drug discovery platform and a growing library of protected chemical structures, Enveric is advancing a pipeline of novel compounds designed …

  9. Enveric Biosciences Unveils EVM401 Series of Compounds with …

    Feb 25, 2025 · Further development of the EVM401 Series of compounds is intended to broaden Enveric’s pipeline with additional non-hallucinogenic molecules and strengthen its ability to …

  10. Stock Information – Enveric Biosciences

    5 days ago · Enveric Biosciences is a development stage company that markets no products at this time. The content of this site is not intended to be promotional or to suggest any product or …